| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf774a9bb87fc7013e8607f0f2a35965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7cca34fe78411d837f1a9df5f2ab692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba8907ba1703c5f029e0fc6dfee76f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a516ab2a437d38fe9cf6817cd52a946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a35aa9dde1db59d5f8c4b6716a3d7b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b05632fe25ae86176bc44ff6a957ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00166780f53b4af62d753e7569e85219 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee2dbbf8fb60e517450b36016951f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce10c06f445a1e1113b51fb09e06a0de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d741fd261b3429b4cb2ed3134faba3b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af861856666427507f111027dad85bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7784bc8d654193846ec2e703126bdb85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69eda56bba86f97fafafdd0547f317cd |
| publicationDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007126832-A2 |
| titleOfInvention |
Pharmaceutical compositions for prevention of overdose or abuse |
| abstract |
The invention relates to pharmaceutical compositions comprised of a chemical moiety attached to an active agent in a manner that substantially decreases the potential of the active agent to cause overdose or to be abused. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011007247-A1 |
| priorityDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |